TRAX
First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics, Inc. (TRAX) has 8 SEC Form 4 filings (8 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 17, 2026.
Insiders have net sold $65.0M over the trailing 6 months.
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$65.0M
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$1.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
EcoR1 Capital, LLCFirst filing | 10% Owner | Sale | 4,705,575 | $65.0M | Apr 22 | SEC ↗ |
Related companies
First Tracks Biotherapeutics, Inc. is in the Healthcare sector.